Variant report
Variant | nsv1022014 |
---|---|
Chromosome Location | chr9:7829069-7844774 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PTPRD-8 | chr9:7833925-7834006 | NONHSAT130179 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs536691261 | chr9:7831606-7831607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs555605861 | chr9:7831651-7831652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs567203579 | chr9:7831684-7831685 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs377384166 | chr9:7831717-7831718 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs187588578 | chr9:7831729-7831730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs373188123 | chr9:7831807-7831808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs143785048 | chr9:7831834-7831835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs553741070 | chr9:7831851-7831852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs118128313 | chr9:7831857-7831858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs112238394 | chr9:7831858-7831859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191023095 | chr9:7831874-7831875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs576548256 | chr9:7831926-7831927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs543782393 | chr9:7831944-7831945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs148573394 | chr9:7831977-7831978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs529599580 | chr9:7831993-7831994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs539898338 | chr9:7833966-7833967 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs545652227 | chr9:7833978-7833979 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs576934139 | chr9:7833991-7833992 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs149526970 | chr9:7834217-7834218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs546744685 | chr9:7834220-7834221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs543505973 | chr9:7834247-7834248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs143666620 | chr9:7834270-7834271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs74815100 | chr9:7834290-7834291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs551140459 | chr9:7834330-7834331 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs569252078 | chr9:7834353-7834354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs561676522 | chr9:7834378-7834379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs368156736 | chr9:7834394-7834395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs545567941 | chr9:7834399-7834400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs138241424 | chr9:7834410-7834411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs554151334 | chr9:7834429-7834430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs566094332 | chr9:7834436-7834437 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs12236892 | chr9:7834442-7834443 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs184335075 | chr9:7834479-7834480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs531434910 | chr9:7834494-7834495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs548068518 | chr9:7834540-7834541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs561692031 | chr9:7834552-7834553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188822689 | chr9:7834558-7834559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs560066158 | chr9:7834599-7834600 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs544117911 | chr9:7834608-7834609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs533687565 | chr9:7834611-7834612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs142758505 | chr9:7834645-7834646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs146107029 | chr9:7834667-7834668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs542105510 | chr9:7834673-7834674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs551765339 | chr9:7834701-7834702 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs140052593 | chr9:7834743-7834744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs191738608 | chr9:7834762-7834763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs540603176 | chr9:7834778-7834779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs565271838 | chr9:7834796-7834797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs535155061 | chr9:7841018-7841019 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs190089750 | chr9:7841023-7841024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Developmental delay | 21147756 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:7831600-7832000 | Enhancers | HSMMtube | muscle |
2 | chr9:7834200-7834400 | Enhancers | Left Ventricle | heart |
3 | chr9:7834200-7834800 | Enhancers | Fetal Brain Male | brain |
4 | chr9:7834400-7834800 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
5 | chr9:7841000-7861200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr9:7843600-7844200 | Enhancers | Fetal Brain Male | brain |
7 | chr9:7844000-7844200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
8 | chr9:7844200-7844600 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
9 | chr9:7844200-7844800 | Enhancers | Brain Hippocampus Middle | brain |
10 | chr9:7844200-7844800 | Enhancers | Brain Substantia Nigra | brain |
11 | chr9:7844200-7845000 | Flanking Active TSS | Primary neutrophils fromperipheralblood | blood |